precision medicine

R&D

Gloved lab hand holds petri dish with AMR test

AI can help us build a new, more precise, antibiotic pipelin...

AI has begun to influence early-stage antibiotic discovery by identifying novel antibacterial compounds that are difficult to uncover traditionally.

News

Blood test samples held by lab technician

Diagnostics lag is holding back new therapies, says study

Advances in therapeutics are outpacing the development of diagnostics due to policy and payment barriers, holding back effective, targeted care.

R&D

A complex biological landscape of protein function unlocked ...

Promise Bio’s advanced AI-driven system integrates proteomics and multi-omics data, focusing on PTMs to identify unique biomarkers % disease pathways.

R&D

Clinical trials, various research areas, concept

Clinical Trials Round-Up – Jan to Feb 2026

Read how Jan-Feb '26 offered a revealing cross-section of how R&D is evolving across therapy areas.

Oncology

Chemicals in test tubes on a rack in a lab

Advancing radiopharmaceutical development: Preclinical preci...

Radiopharmaceutical development must move beyond fixed paradigms toward patient-specific, data-driven optimisation.

R&D

What’s holding back precision medicine outside oncology?

Precision medicine is finding success in cancer care, but not much elsewhere. The reasons why are often more economic than scientific.